NDC11 65757065242
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 65757-0652-42 | 65757-0652 |
| 65757-652-42 | 65757-652 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LYBALVI | OLANZAPINE AND SAMIDORPHAN L-MALATE | Alkermes, Inc. | 32ffddd1-4e2b-45d9-9b36-bb730167ec80 | 2026-01-31 | Boxed warning, Warnings, Adverse reactions | 65757-652-42 65757-652 65757065242 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.